---
layout: default
title: Scopolamine
description: "Scopolamine çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 6 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 155
evidence_level: L5
indication_count: 6
---

# Scopolamine

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>6</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Scopolamineï¼šå¾è§£ç—™åŠ‘åˆ°ç¥ç¶“åŠçœ¼ç§‘ç–¾ç—…æ¢ç´¢

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Scopolamine å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Scopolamine ä¸»è¦ç”¨æ–¼èƒƒè…¸é“ã€è†½é“åŠå°¿è·¯ç—™æ”£çš„ç·©è§£ã€‚
TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**é¦¬å°¾ç—‡å€™ç¾¤ (Cauda Equina Syndrome)** åŠ**ç¥ç¶“æºæ€§è†€èƒ±**æœ‰æ•ˆï¼Œ
ä½†ç›®å‰ç¼ºä¹è‡¨åºŠè©¦é©—åŠæ–‡ç»æ”¯æŒé€™äº›æ–°é©æ‡‰ç—‡ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | èƒƒè…¸ç—™æ”£ã€è†½ç®¡ç—™æ”£ã€å°¿è·¯ç—™æ”£ã€å¥³æ€§ç”Ÿæ®–å™¨ç—™æ”£ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | irritable bowel syndromeã€cauda equina syndromeã€obsolete neurogenic bladder (disease)ã€papillary conjunctivitisã€atopic conjunctivitisã€rosacea conjunctivitis |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.99% |
| è­‰æ“šç­‰ç´š | L5 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | 317 å¼µ |
| å»ºè­°æ±ºç­– | Hold |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. cauda equina syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Scopolamineï¼ˆæ±è¨èªé¹¼ï¼‰æ˜¯ä¸€ç¨®æŠ—è†½é¹¼è—¥ç‰©ï¼Œä½œç‚ºæ¯’è•ˆé¹¼å—é«”æ‹®æŠ—åŠ‘ï¼Œ</p>
<p>èƒ½æŠ‘åˆ¶å‰¯äº¤æ„Ÿç¥ç¶“æ´»å‹•ï¼Œé”åˆ°è§£ç—™åŠæ¸›å°‘åˆ†æ³Œçš„æ•ˆæœã€‚</p>

<p><strong>TxGNN é æ¸¬çš„æ–°é©æ‡‰ç—‡èˆ‡æ©Ÿè½‰é—œè¯æ€§åˆ†æï¼š</strong></p>

<table>
<thead>
<tr>
<th>æ’å</th>
<th>é æ¸¬é©æ‡‰ç—‡</th>
<th>é æ¸¬åˆ†æ•¸</th>
<th>TxGNN æ’å</th>
<th>æ©Ÿè½‰é—œè¯æ€§</th>
</tr>
</thead>
<tbody>
<tr>
<td>1</td>
<td>Cauda Equina Syndromeï¼ˆé¦¬å°¾ç—‡å€™ç¾¤ï¼‰</td>
<td>99.99%</td>
<td>548</td>
<td>å¯èƒ½ç·©è§£ç¥ç¶“å£“è¿«å¼•èµ·çš„è†€èƒ±ç—™æ”£</td>
</tr>
<tr>
<td>2</td>
<td>Neurogenic Bladderï¼ˆç¥ç¶“æºæ€§è†€èƒ±ï¼‰</td>
<td>99.98%</td>
<td>909</td>
<td>æŠ—è†½é¹¼ä½œç”¨å¯ç·©è§£è†€èƒ±éå‹•</td>
</tr>
<tr>
<td>3</td>
<td>Papillary Conjunctivitisï¼ˆä¹³é ­ç‹€çµè†œç‚ï¼‰</td>
<td>99.98%</td>
<td>1,025</td>
<td>é—œè¯æ€§ä¸æ˜ç¢º</td>
</tr>
<tr>
<td>4</td>
<td>Atopic Conjunctivitisï¼ˆç•°ä½æ€§çµè†œç‚ï¼‰</td>
<td>99.80%</td>
<td>4,736</td>
<td>é—œè¯æ€§ä¸æ˜ç¢º</td>
</tr>
<tr>
<td>5</td>
<td>Rosacea Conjunctivitisï¼ˆé…’ç³Ÿçµè†œç‚ï¼‰</td>
<td>99.40%</td>
<td>11,144</td>
<td>é—œè¯æ€§ä¸æ˜ç¢º</td>
</tr>
<tr>
<td>6</td>
<td>Vernal Conjunctivitisï¼ˆæ˜¥å­£çµè†œç‚ï¼‰</td>
<td>99.08%</td>
<td>15,822</td>
<td>é—œè¯æ€§ä¸æ˜ç¢º</td>
</tr>
</tbody>
</table>

<p>é¦¬å°¾ç—‡å€™ç¾¤åŠç¥ç¶“æºæ€§è†€èƒ±çš„é æ¸¬è¼ƒç‚ºåˆç†ï¼Œå› ç‚º Scopolamine çš„æŠ—è†½é¹¼ä½œç”¨å¯ç·©è§£è†€èƒ±éå‹•åŠç—™æ”£ç—‡ç‹€ã€‚</p>
<p>ç„¶è€Œï¼Œçµè†œç‚ç›¸é—œé æ¸¬èˆ‡å·²çŸ¥æ©Ÿè½‰é—œè¯æ€§è¼ƒå¼±ã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. obsolete neurogenic bladder (disease)</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. papillary conjunctivitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.98%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. atopic conjunctivitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.80%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. rosacea conjunctivitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.40%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. vernal conjunctivitis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.08%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ | ç‹€æ…‹ |
|---------|------|------|-----------|------|
| å…§è¡›è—¥è£½å­—ç¬¬000509è™Ÿ | ä¿è³œåº·è† å›Š | è† å›ŠåŠ‘ | èƒƒæ½°ç˜ã€è†½å›Šç‚ã€è†½çµçŸ³ã€å°¿è·¯çµçŸ³ã€è†€èƒ±ç—™æ”£ã€ç—™æ”£æ€§æœˆç¶“å›°é›£ç­‰ | æœ‰æ•ˆ |
| å…§è¡›è—¥è£½å­—ç¬¬002211è™Ÿ | å¼·ç”Ÿèˆ’èƒƒç³–è¡£éŒ 10æ¯«å…‹ | éŒ åŠ‘ | èƒƒç‚ã€è…¸ç–ç—›ã€è†½ç®¡ç—™æ”£ã€è†½çŸ³ç–ç—› | æœ‰æ•ˆ |
| å…§è¡›è—¥è£½å­—ç¬¬009840è™Ÿ | å‹¿è³œç—›æ³¨å°„æ¶² | æ³¨å°„åŠ‘ | è…¸ç–ç—›ã€è†½ç®¡ç—™æ”£ã€è†½çŸ³ç–ç—›ã€ç—™æ”£æ€§æœˆç¶“å›°é›£ç—‡ | æœ‰æ•ˆ |
| å…§è¡›è—¥è£½å­—ç¬¬010222è™Ÿ | å—å…‰èƒƒä½¿å¯èƒ–æ³¨å°„æ¶² | æ³¨å°„åŠ‘ | èƒƒè…¸ç—™æ”£ã€è†½ç®¡ç—™æ”£ã€å°¿è·¯ç—™æ”£ã€å¥³æ€§ç”Ÿæ®–å™¨ç—™æ”£ | æœ‰æ•ˆ |
| å…§è¡›è—¥è£½å­—ç¬¬001758è™Ÿ | æ”£æ€•æ–¯ç³–è¡£ç‰‡ | ç³–è¡£éŒ  | èƒƒè…¸ç—™æ”£ã€è†½ç®¡ç—™æ”£ã€å°¿è·¯ç—™æ”£ | æœ‰æ•ˆ |

## å®‰å…¨æ€§è€ƒé‡

- **ä¸»è¦è—¥ç‰©äº¤äº’ä½œç”¨ï¼ˆé‡å¤§ï¼‰**ï¼š
  - Topiramateã€Zonisamideï¼šå¯èƒ½å¢åŠ é«”æº«èª¿ç¯€éšœç¤™é¢¨éšª

- **ä¸­åº¦è—¥ç‰©äº¤äº’ä½œç”¨**ï¼š
  - é´‰ç‰‡é¡è—¥ç‰©ï¼šFentanylã€Morphineã€Codeineã€Hydrocodoneã€Tramadolã€Buprenorphine ç­‰
  - æŠ—è†½é¹¼è—¥ç‰©ï¼šAtropineã€Hyoscyamineã€Glycopyrroniumã€Benzatropine ç­‰
  - æŠ—ç²¾ç¥ç—…è—¥ç‰©ï¼šAripiprazoleã€Asenapineã€Brexpiprazole ç­‰
  - æŠ—çµ„ç¹”èƒºè—¥ç‰©ï¼šChlorpheniramineã€Brompheniramine ç­‰
  - ä¹™å‹é˜»æ–·åŠ‘ï¼šAtenololã€Bisoprololã€Acebutolol ç­‰
  - å…¶ä»–ï¼šEthanolã€Amantadineã€Amitriptylineã€Loperamide

- **è¼•åº¦è—¥ç‰©äº¤äº’ä½œç”¨**ï¼š
  - Acetaminophenã€Hydrochlorothiazide

å®‰å…¨æ€§è³‡è¨Šè«‹åƒè€ƒåŸå» ä»¿å–®ã€‚


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é«˜è¡€å£“** ğŸ”´ Major
- æ³¨æ„äº‹é …ï¼šCardiovascular effects of anticholinergics may exacerbate hypertension...

**ç”²ç‹€è…ºæ©Ÿèƒ½äº¢é€²** ğŸ”´ Major
- éœ€å®šæœŸç›£æ¸¬ã€‚

**Diarrhea** ğŸ”´ Major
- æ³¨æ„äº‹é …ï¼šDiarrhea may be a symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy...

**Fever** ğŸ”´ Major
- æ³¨æ„äº‹é …ï¼šAtropine-like agents may increase the risk of hyperthermia in patients with fever by producing anhidrosis...

**Heart Diseases** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šAnticholinergics block vagal inhibition of the SA nodal pacemaker...

**å¿ƒæéé€Ÿ** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šAnticholinergics block vagal inhibition of the SA nodal pacemaker...

**Coronary Artery Disease** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šAntimuscarinic agents block vagal inhibition of the SA nodal pacemaker...

**Stomach Ulcer** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šAntimuscarinic agents may cause a delay in gastric emptying and possibly antral stasis in patients with gastric ulcer...

**Gastroesophageal Reflux** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šAntimuscarinic agents decrease gastric motility and relax the lower esophageal sphincter which promotes gastric retention and can aggravate reflux...

**Colitis, Ulcerative** ğŸŸ¡ Moderate
- æ³¨æ„äº‹é …ï¼šAntimuscarinic agents may suppress intestinal motility and produce paralytic ileus with resultant precipitation of toxic megacolon...

**Diabetic Neuropathies** ğŸŸ¢ Minor
- æ³¨æ„äº‹é …ï¼šAgents with anticholinergic activity can exacerbate many of the manifestations of autonomic neuropathy, including tachycardia, anhidrosis, bladder ato...

**Intestinal Obstruction** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

**é’å…‰çœ¼** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**Urinary Bladder Neck Obstruction** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚ç‰¹åˆ¥æ³¨æ„æ—ç¾¤ï¼šè€å¹´äººã€‚

**Lung Diseases** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

**é‡ç—‡è‚Œç„¡åŠ›** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

**Dysentery** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é…’ç²¾** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šç”¢ç”Ÿå”åŒä½œç”¨ã€‚å¯èƒ½å¢å¼·è—¥æ•ˆã€‚
- å»ºè­°ï¼šå»ºè­°é¿å…ä½µç”¨ã€‚

**é£Ÿç‰©** ğŸ”´ Major
- å½±éŸ¿ï¼šå½±éŸ¿è—¥ç‰©å¸æ”¶ã€‚å¯èƒ½å¢åŠ è—¥ç‰©å¸æ”¶ã€‚
- å»ºè­°ï¼šå»ºè­°é–“éš”æœç”¨ã€‚


## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šHold**

**ç†ç”±ï¼š**
TxGNN é æ¸¬çš„é¦¬å°¾ç—‡å€™ç¾¤åŠç¥ç¶“æºæ€§è†€èƒ±é©æ‡‰ç—‡èˆ‡ Scopolamine çš„æŠ—è†½é¹¼ä½œç”¨æ©Ÿè½‰æœ‰ä¸€å®šé—œè¯ï¼Œ
ä½†ç›®å‰ç¼ºä¹è‡¨åºŠè©¦é©—åŠæ–‡ç»æ”¯æŒã€‚çµè†œç‚ç›¸é—œé æ¸¬å‰‡èˆ‡å·²çŸ¥æ©Ÿè½‰é—œè¯æ€§è¼ƒå¼±ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- é‡å°ç¥ç¶“æºæ€§è†€èƒ±çš„è‡¨åºŠè©¦é©—æ•¸æ“š
- æ¢ç´¢ Scopolamine åœ¨é¦¬å°¾ç—‡å€™ç¾¤ç›¸é—œè†€èƒ±åŠŸèƒ½éšœç¤™çš„æ‡‰ç”¨
- è©•ä¼°é•·æœŸä½¿ç”¨çš„å®‰å…¨æ€§ï¼Œç‰¹åˆ¥æ˜¯èˆ‡å…¶ä»–æŠ—è†½é¹¼è—¥ç‰©ä½µç”¨æ™‚

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Methocarbamol]({{ "/drugs/methocarbamol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Leflunomide]({{ "/drugs/leflunomide/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Xylitol]({{ "/drugs/xylitol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Cephalexin]({{ "/drugs/cephalexin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Travoprost]({{ "/drugs/travoprost/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Scopolamineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/scopolamine/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_scopolamine,
  title = {Scopolamineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/scopolamine/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
